1 - 25 of
58
results
for author:"Dragani T.A."
in Literature Citations
| FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Falvella F.S., Frullanti E., Galvan A., Spinola M., Noci S., De Cecco L., Nosotti M., Santambrogio L., Incarbone M., Alloisio M. et al. Int. J. Cancer 124:2880-2885(2009) · Mapped (7) |
| Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors. Manenti G., Trincucci G., Pettinicchio A., Amendola E., Scarfo M., Dragani T.A. Oncogene 27:5753-5758(2008) · Mapped (5) |
| BHLHB3: a candidate tumor suppressor in lung cancer. Falvella F.S., Colombo F., Spinola M., Campiglio M., Pastorino U., Dragani T.A. Oncogene 27:3761-3764(2008) · Mapped (5) |
| AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status. Falvella F.S., Spinola M., Pignatiello C., Noci S., Conti B., Pastorino U., Carbone A., Dragani T.A. Oncogene 27:1650-1656(2008) · Mapped (2) |
| Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Spinola M., Leoni V.P., Galvan A., Korsching E., Conti B., Pastorino U., Ravagnani F., Columbano A., Skaug V., Haugen A. et al. Cancer Lett. 251:311-316(2007) · Mapped (4) |
| Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk. Falvella F.S., Spinola M., Manenti G., Conti B., Pastorino U., Skaug V., Haugen A., Dragani T.A. Lung Cancer 56:1-7(2007) · Mapped (9) |
| Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival. Spinola M., Falvella F.S., Galvan A., Pignatiello C., Leoni V.P., Pastorino U., Paroni R., Chen S., Skaug V., Haugen A. et al. Lung Cancer 55:271-277(2007) · Mapped (21) |
| Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. Spinola M., Meyer P., Kammerer S., Falvella F.S., Boettger M.B., Hoyal C.R., Pignatiello C., Fischer R., Roth R.B., Pastorino U. et al. J. Clin. Oncol. 24:1672-1678(2006) · Mapped (4) |
| Identification of RASSF8 as a candidate lung tumor suppressor gene. Falvella F.S., Manenti G., Spinola M., Pignatiello C., Conti B., Pastorino U., Dragani T.A. Oncogene 25:3934-3938(2006) · Mapped (4) |
| Allelic effects of mouse Pas1 candidate genes in human lung cancer cell lines. Galbiati F., Pettinicchio A., Dragani T.A., Manenti G. Cancer Lett. 244:176-181(2006) · Mapped (14) |
| A V141L polymorphism of the human LRMP gene is associated with survival of lung cancer patients. Manenti G., Galbiati F., Pettinicchio A., Spinola M., Piconese S., Leoni V.P., Conti B., Ravagnani F., Incarbone M., Pastorino U. et al. Carcinogenesis 27:1386-1390(2006) · UniProtKB (1) · Mapped (7) |
| Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients. Spinola M., Leoni V., Pignatiello C., Conti B., Ravagnani F., Pastorino U., Dragani T.A. J. Clin. Oncol. 23:7307-7311(2005) · Mapped (7) |
| FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Spinola M., Leoni V.P., Tanuma J., Pettinicchio A., Frattini M., Signoroni S., Agresti R., Giovanazzi R., Pilotti S., Bertario L. et al. Oncol. Rep. 14:415-419(2005) · Mapped (7) |
| Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Raimondi S., Boffetta P., Anttila S., Brockmoller J., Butkiewicz D., Cascorbi I., Clapper M.L., Dragani T.A., Garte S., Gsur A. et al. Mutat. Res. 592:45-57(2005) · Mapped (20) |
| Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer. Spinola M., Galvan A., Pignatiello C., Conti B., Pastorino U., Nicander B., Paroni R., Dragani T.A. |
| Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis. Zaffaroni D., Spinola M., Galvan A., Falvella F.S., Pazzaglia S., Saran A., Mancuso M.T., Galbiati F., Pignatiello C., Cabrera W. et al. |
| Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis. Spinola M., Pedotti P., Dragani T.A., Taioli E. Clin. Cancer Res. 10:4769-4775(2004) · Mapped (4) |
| A new polymorphism (Ser362Thr) of the L-myc gene is not associated with lung adenocarcinoma risk and prognosis. Spinola M., Conti B., Ravagnani F., Fabbri A., Incarbone M., Cataldo I., Pira E., Pelucchi C., La Vecchia C., Dragani T.A. Eur. J. Cancer Prev. 13:87-89(2004) · UniProtKB (1) · Mapped (3) |
| Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Manenti G., Galbiati F., Gianni-Barrera R., Pettinicchio A., Acevedo A., Dragani T.A. |
| Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration. Benelli R., Peissel B., Manenti G., Gariboldi M., Vanzetto C., Albini A., Dragani T.A. |
| SCCA2-like serpins mediate genetic predisposition to skin tumors. Gariboldi M., Peissel B., Fabbri A., Saran A., Zaffaroni D., Falvella F.S., Spinola M., Tanuma J., Pazzaglia S., Mancuso M.T. et al. |
| Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response. Maria D.A., Manenti G., Galbiati F., Ribeiro O.G., Cabrera W.H., Barrera R.G., Pettinicchio A., De Franco M., Starobinas N., Siqueira M. et al. Oncogene 22:426-432(2003) · Mapped (19) |
| Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H. et al. Nature 420:563-573(2002) · UniProtKB (17,872) · Mapped (20,305) |
| Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Falvella F.S., Pascale R.M., Gariboldi M., Manenti G., De Miglio M.R., Simile M.M., Dragani T.A., Feo F. Carcinogenesis 23:1933-1936(2002) · UniProtKB (2) · Mapped (2) |
| Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci. Peissel B., Zaffaroni D., Pazzaglia S., Manenti G., Zanesi N., Zedda I., Rebessi S., Covelli V., Dragani T.A., Saran A. Mamm. Genome 12:291-294(2001) · Mapped (16) |
